Idarubicin. 4-Desmethoxydaunorubicin . IMI-30 . Idarubicin Hydrochloride . NSC-256439 . 4 Demethoxydaunorubicin . 4 Desmethoxydaunorubicin . Hydrochloride, Idarubicin . IMI 30 . IMI30 . NSC 256439 . NSC256439 . 4-Demethoxydaunorubicin . An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA. . 0.36
Rituximab. CD20 Antibody, Rituximab . GP2013 . IDEC-C2B8 . IDEC-C2B8 Antibody . Mabthera . Rituxan . IDEC C2B8 . IDEC C2B8 Antibody . Rituximab CD20 Antibody . A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. . 0.36
Antigens, Neoplasm. Antigens, Tumor . Neoplasm Antigens . Tumor Antigens . Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. . 0.35